10,000 results · 45ms · Sources: EU EUDAMED, US FDA

IMX(R) TOXO IGM

FDA 510(k)
FDA Class 2 ·Microbiology

IMX FREE T4 CALCULATION

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

IMX CA 15-3

FDA 510(k)
FDA Class 2 ·Immunology

ABBOTT IMX PROLACTIN(MODIFICATION)

FDA 510(k)
FDA Class 1 ·Clinical Chemistry

MODIFICATION TO IMX HOMOCYSTEINE

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

IMX TOTAL B-HCG

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

ABBOTT IMX 2 ANALYZER

FDA 510(k)
FDA Class 1 ·Clinical Chemistry

ABBOTT IMX FREE T4

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

IMX(R) GLYCATED HEMOGLOBIN

FDA 510(k)
FDA Class 2 ·Hematology

IMX TOTAL B-HCG

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

IMX ULTRASENSISTIVE HTSH II

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

Hepatitis A Test (Antibody And Igm Antibody)

FDA Pre-Market Approval
FDA Class 2 ·IMX HAVAB -M (LIST NUMBER 2263)

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval
FDA Class 2 ·IMX AND AXSYM PSA

Kit, Test,Alpha-Fetoprotein For Testicular Cancer

FDA Pre-Market Approval
FDA Class 2 ·ABBOTT IMX AFP ASSAY

Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions

FDA Pre-Market Approval
FDA Class 3 ·ABBOTT IMX FREE PSA

Enzyme Immunoassay, Tracrolimus

FDA Pre-Market Approval
FDA Class 2 ·IMX TACROLIMUS II ASSAY

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA Pre-Market Approval
FDA Class 2 ·ABBOTT IMX(R) PSA*

Enzyme Immunoassay, Tracrolimus

FDA Pre-Market Approval
FDA Class 2 ·ABBOTT IMX TACROLIMUS II

IMX CMV IGG ANTIBODY ASSAY

FDA 510(k)
FDA Class 2 ·Microbiology

ABBOTT IMX(TM) D-DIMER

FDA 510(k)
FDA Class 2 ·Hematology